Drug Studies Banaga Ali

  • June 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Drug Studies Banaga Ali as PDF for free.

More details

  • Words: 442
  • Pages: 3
LOURDES COLLEGE Nursing Department

Maria Theresa Bido/BSN-4

Clinical Instructor: Mr. Jared Betita, RN DRUG STUDY

Client: Ali Rocaya GENERIC CLASSIFICA (BRAND) TION NAME

INDICATION

MECHANISM OF

NURSING

ACTION

PRECAUTION

Gastric acid-pump inhibitor: Suppresses gastric acid secretion by specific inhibition of the hydrogenpotassium ATPase enzyme system at the secretory surface of the gastric parietal cells; blocks the final step of acid production.

ASSESSMENT

ROUTE

[DATE ORDERED]

omeprazol e

DOSE/TIMIN G/

Antisecretory agent

40 g tab OD PO

First-line therapy in treatment of heartburn

Proton pump inhibitor

ADVERSE REACTIONS

CONTRAINDICATION

• CNS: Headache, dizziness, asthenia, vertigo, insomnia, apathy, anxiety, paresthesias, dream abnormalities • Dermatologic: Rash, inflammation, urticaria, pruritus, alopecia, dry skin • GI: Diarrhea, abdominal pain, nausea, vomiting, constipation, dry mouth, tongue atrophy

• History: Hypersensitivity to omeprazole or any of its components; pregnancy, lactation • Physical: Skin lesions; T; reflexes, affect; urinary output, abdominal exam; respiratory auscultation

PLANNING • Administer before meals. Caution patient to swallow capsules whole—not to open, chew, or crush them. • Arrange for further evaluation of patient after 8 wk of therapy for gastroreflux disorders; not intended for maintenance therapy. Symptomatic improvement does not rule out gastric cancer, which did occur in preclinical studies. • Administer antacids with omeprazole, if needed. Teaching points • Take the drug before meals. Swallow the capsules whole; do

• Contraindicated with hypersensitivity to omeprazole or its components. • Use cautiously with pregnancy, lactation.

• Respiratory: URI symptoms, cough, epistaxis • Other: Cancer in preclinical studies, back pain, fever

not chew, open, or crush them. This drug will need to be taken for up to 8 wk (short-term therapy) or for a prolonged period (> 5 yr in some cases). • Have regular medical follow-up visits. • These side effects may occur: Dizziness (avoid driving or performing hazardous tasks); headache (request medications); nausea, vomiting, diarrhea (maintain proper nutrition); symptoms of upper respiratory tract infection, cough (do not self-medicate; consult with your health care provider if uncomfortable). • Report severe headache, worsening of symptoms, fever, chills.

EVALUATION Patient will show absence of heartburn.

CLIENT: Ali Rocaya GENERIC CLASSIFICA (BRAND) TION NAME

INDICATION

MECHANISM OF

NURSING

ACTION

PRECAUTION

ROUTE

[DATE ORDERED]

simethicon e

DOSE/TIMIN G/

Antifoaming agent

125 mg 1 tab BID PO

Relief of painful symptoms and pressure of excess gas in digestive system.

Relieves flatulence by dispersing and preventing formation of gas pocket in the GI system.

ASSESSMENT Assess bowels sounds, belching and passage of flatus

ADVERSE REACTIONS No known adverse reactions

PLANNING

Give after meals and at bedtime Emphasize the importance of diet and exercise in the prevention of gas Advise patient to develop regular bowel movement

CONTRAINDICATION Hypersentivity

EVALUATION Absence of flatulence

Related Documents

Drug Studies
June 2020 8
Ali Ali
June 2020 41
Ali
November 2019 55